Division of Cardiology, Department of Medicine, Cardiac and Vascular Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
J Korean Med Sci. 2013 Jun;28(6):951-4. doi: 10.3346/jkms.2013.28.6.951. Epub 2013 Jun 3.
Percutaneous catheter-based therapy has recently been introduced to decrease blood pressure by ablation of efferent and afferent sympathetic renal nerves. The patient described here had a seven-year history of hypertension and presented with poorly controlled blood pressure despite antihypertensive therapy with four different drugs. A 44-yr-old man underwent percutaneous renal denervation under local anesthesia using an ablation catheter. After six months of follow-up his blood pressure had dropped 49/37 mmHg with a decrease in 24-hr ambulatory BP of 20/18 mmHg. Renal Doppler ultrasound showed no significant stenosis in either renal artery. This is the first case of successful percutaneous renal denervation, which has recently become available in Korea.
经皮导管介入治疗最近被引入，通过消融传出和传入的交感神经肾神经来降低血压。这里描述的患者患有七年的高血压病史，尽管使用了四种不同的降压药物治疗，但血压仍控制不佳。一名 44 岁的男性在局部麻醉下使用消融导管进行经皮肾去神经支配。随访六个月后，他的血压下降了 49/37mmHg，24 小时动态血压下降了 20/18mmHg。肾多普勒超声显示双侧肾动脉均无明显狭窄。这是首例在韩国成功进行的经皮肾去神经支配手术。
